• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-550-525 Revised 13-Sep-07
ZJ-43
Add to Clipboard
PRODUCT LINE Neurobiology
PRODUCT CATEGORY NAALADase / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-550-525-M002   2 mg 190.00 USD Add To Cart
Product Specification
FORMULA: C12H20N2O7
MW: 304.3
PURITY: ≥97% (HPLC)
APPEARANCE: White to off-white solid.
SOLUBILITY: Soluble in water, methanol, 100% ethanol or DMSO.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Hygroscopic.

Product Description
Potent inhibitor of N- acetylaspartylglutamate (NAAG) peptidases, glutamate carboxypeptidase II (NAALADase I) (Ki=0.8nm) and glutamate carboxypeptidase III  (NAALADase II) (Ki=23nm). Group II metabotropic glutamate receptor (mGluR) agonist.
Product Specific Literature References
NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR: R.T. Olszewski, et al.; J. Neurochem. 89, 876 (2004) Abstract
NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat: C. Zhong, et al.; J. Neurochem. 97, 1015 (2006) Abstract
Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats: T. Yamamoto, et al.; Eur. J. Neurosci. 25, 147 (2007) Abstract
 
 

Your items will be kept only for the duration of your visit.